Leica Biosystems has announced an affiliate has agreed to acquire Aperio, according to a news release.
Aperio is a provider of ePathology solutions based in Vista, Calif.
Following the acquisition, Aperio will be integrated into Leica Biosystems, an anatomical pathology solutions. Aperio's customers include clinicians and researchers working in hospitals, reference laboratories, pharma and research institutions.
"We are excited to acquire Aperio, because of its leadership in digital pathology, innovative product portfolio, and its very experienced global team," said Arnd Kaldowski, president of Leica Biosystems, in the release. "We share the commitment to advancing cancer diagnostics to improve lives. This acquisition positions us to better address the growing demand for personalized medicine and the increasing challenge of staff shortage in the global pathology market. Together we offer the market an end-to-end solution from the time that the specimen is collected to the time that the results are delivered, to help our customers improve workflow efficiency and diagnostic confidence."
Leica Biosystems is headquartered in Nussloch, Germany.
Related Articles on Company Acquisitions:
Teleflex Completes Sale of OEM Orthopedics Business to Tecomet
Kinetic Concepts to Sell Therapeutic Support Systems Business to Getinge AB for $275M
CONMED to Acquire Viking Systems for $22.5M